Cargando…
Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
BACKGROUND: We have previously shown that the long non-coding (lnc)RNA prostate cancer associated 3 (PCA3; formerly prostate cancer antigen 3) functions as a trans-dominant negative oncogene by targeting the previously unrecognized prostate cancer suppressor gene PRUNE2 (a homolog of the Drosophila...
Autores principales: | Lauer, Richard C, Barry, Marc, Smith, Tracey L, Thomas, Andrew Maltez, Wu, Jin, Du, Ruofei, Lee, Ji-Hyun, Rao, Arpit, Dobroff, Andrey S, Arap, Marco A, Nunes, Diana N, Silva, Israel T, Dias-Neto, Emmanuel, Chen, Isan, McCance, Dennis J, Cavenee, Webster K, Pasqualini, Renata, Arap, Wadih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886275/ https://www.ncbi.nlm.nih.gov/pubmed/36645410 http://dx.doi.org/10.7554/eLife.81929 |
Ejemplares similares
-
Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses
por: Teixeira, Andre A, et al.
Publicado: (2017) -
Vascular Targeting: Recent Advances and Therapeutic Perspectives
por: Hajitou, Amin, et al.
Publicado: (2006) -
Aminopeptidase N inhibitors and SARS
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2003) -
Brain endothelial cell‐targeted gene therapy of neurovascular disorders
por: Marchiò, Serena, et al.
Publicado: (2016) -
Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies
por: Staquicini, Fernanda I., et al.
Publicado: (2019)